RVX208 inhibits proliferation, promotes apoptosis, ameliorates inflammation through the BRD4-FoxM1-PLK1 axis in PAH-associated vessels, and improves vascular remodeling and pulmonary hemodynamics in rats in vivo [197]. Here, FOXM1 is linked to pulmonary arterial hypertension.